Financial Reports Latest Updates Industry Maps Economic Calendar

Wave Life Sciences Ltd. (WVE) Annual Reports

Q: Where can I read Wave Life Sciences Ltd. (WVE) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Wave Life Sciences Ltd. is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1631574 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$2.3M	$8.7M	-73.9%
Operating income	$-73.8M	$-52.8M	-39.9%
Net income	$-69.4M	$-50.5M	-37.4%
EPS (diluted)	$-0.34	$-0.31	-9.7%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 2.27 mn Net income -69.3 mn

Show table：Income statement

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	—	—	0.03	0.13	0	0	—	0.42	0.39	0.68	0.38	1.10	1.32	1.10	1.42	4.88	4.49	3.62	3.03	7.63	2.93	2.40	4.16	3.03	3.45	9.44	—	2.78	36.4	1.77	1.75	0.38	0.28	1.24	12.9	22.1	49.2	29.1	12.5	19.7	—	76.1	9.18	8.70	—	24.9	38.3	2.27
Operating income	-3.57	—	—	-1.35	-1.78	-3.46	-3.63	-4.99	-7.21	-7.95	-11.6	-17.2	-18.5	-19.9	-25.1	-27.0	-30.6	-35.8	-36.6	-38.2	-48.9	-48.0	-45.6	-54.2	-60.5	-50.0	-38.7	-34.4	-30.3	-43.5	-39.8	-7.61	-36.1	-38.1	-42.2	-38.9	-43.6	-30.3	-23.5	4.44	-18.7	-34.5	-35.0	-63.9	23.0	-49.8	-52.8	-56.4	-56.5	-31.3	-73.8
Net income	-3.32	-0.4	-1.72	-1.36	-1.75	-3.46	-3.70	-4.94	-7.10	-7.85	-11.6	-17.5	-18.4	-21.0	-24.7	-26.1	-30.2	-35.2	-35.9	-37.6	-37.9	-44.2	-41.9	-50.7	-56.8	-47.5	-40.5	-33.1	-28.8	-42.5	-38.8	-6.23	-34.8	-37.8	-41.3	-39.0	-43.7	-27.4	-21.1	7.25	-16.3	-31.6	-32.9	-61.8	29.3	-46.9	-50.5	-53.9	-53.2	-26.1	-69.3

Balance sheet

Quarterly · In mn (USD)

Total assets 558 mn Total liabilities 105 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	—	1.49	—	—	68.0	161	154	184	172	152	133	201	174	150	118	268	233	202	315	290	250	185	150	147	258	230	195	159	158	163	124	160	131	98.5	220	185	159	235	197	172	325	320	258	224	215	615	561	508
Total assets	—	—	—	—	2.94	—	—	71.0	165	159	190	180	165	152	226	202	182	150	354	325	296	431	386	347	284	239	204	310	279	243	206	201	207	167	213	182	146	267	230	200	275	235	209	359	352	288	252	241	639	584	558
Current liabilities	—	—	—	—	0.88	—	—	3.47	3.82	3.77	8.65	11.4	12.2	14.1	15.6	15.1	19.6	16.3	43.8	126	130	132	124	133	118	119	110	110	121	48.7	46.7	31.6	64.2	58.5	64.1	64.3	71.5	133	140	100.0	186	166	173	171	111	87.4	87.4	85.9	95.1	49.8	50.8
Total liabilities	—	—	—	—	0.91	—	—	3.60	4.06	4.13	16.2	21.0	22.1	26.6	29.6	28.4	34.2	32.5	207	210	215	226	217	225	213	210	201	194	189	182	177	163	167	160	175	178	184	294	274	233	227	202	204	209	135	109	105	109	112	71.8	105
Equity	-7.76	—	—	—	2.03	—	—	-3.12	153	147	166	151	135	117	189	166	140	110	139	107	73.3	197	160	115	63.7	20.9	-4.49	108	82.8	52.8	21.8	29.9	32.5	-0.05	30.9	-4.52	-45.1	-34.7	-51.7	-40.5	39.6	25.4	-3.48	142	210	172	139	125	518	512	454

Cash flow

Quarterly · In mn (USD)

Operating -53.6 mn Investing -123 mn Financing 0.33 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-3.55	—	—	-3.19	-1.23	-1.62	-1.39	-2.85	-6.67	-7.14	0.39	-11.8	-13.3	-17.4	-20.1	-23.4	-22.8	-32.4	71.4	-29.0	-32.8	-50.4	-32.9	-43.7	-61.2	-26.3	-38.1	-20.2	-31.4	-44.4	-9.40	-28.2	-7.03	-39.9	-28.8	-25.6	-33.4	85.5	-37.3	-34.5	-33.2	-33.4	-27.5	-46.5	-43.6	-63.0	-46.0	-44.7	-33.8	-59.5	-53.6
Investing	-0.05	—	—	-0.25	-0.01	-0.07	-1.36	-0.51	-0.97	-0.68	-0.87	-1.27	-2.73	-3.64	-5.56	-5.61	-4.08	-1.16	-1.92	-3.39	-3.46	-0.51	-1.60	-0.46	-1.35	-0.58	-0.14	-0.06	-0.56	-0.11	-0.34	-0.1	-0.01	-50.2	24.6	-0.5	24.8	-0.49	-0.07	-0.2	-0.36	-0.42	-0.05	-0.38	-0.09	-0.16	-0.31	-0.25	0	-0.44	-123
Financing	3.67	—	—	5.62	0	11.6	0.02	61.2	103	-0.02	28.9	0.18	0.02	0.19	93.5	0.06	0.59	1.54	61.6	1.35	0.65	164	-0.16	0.25	0.76	0.61	11.4	143	0.02	8.64	5.05	8.35	33.8	1.32	65.8	0.02	0.06	35.0	1.85	1.67	94.0	14.5	0.65	204	35.0	4.16	11.7	32.7	440	2.53	0.33
Cash at period end	0.44	—	—	2.49	1.05	11.0	7.78	66.0	161	153	182	169	150	129	197	168	143	110	241	210	175	288	253	209	147	121	94.0	216	185	149	144	124	151	61.7	123	97.0	88.5	208	173	140	200	181	154	311	302	243	208	196	602	545	368

Profitability

Quarterly · %

Operating margin -3248.3% Net margin -3052.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	—	—	—	—	—	-13326.9%	-2880.2%	—	—	—	-2790.9%	-4396.2%	-2737.3%	-5199.5%	-2287.5%	-2052.6%	-2785.1%	-2515.8%	-749.6%	-850.9%	-1352.0%	-1585.9%	-598.0%	-1849.7%	-2522.2%	-1201.5%	-1277.0%	-997.5%	-321.1%	—	-1434.7%	-20.9%	-2045.9%	-2176.8%	-11243.7%	-13648.8%	-3516.0%	-234.2%	-106.2%	9.0%	-64.3%	-274.8%	-177.7%	—	30.2%	-542.8%	-606.5%	—	-227.2%	-81.8%	-3248.3%
Net margin	—	—	—	—	—	-13326.9%	-2936.5%	—	—	—	-2773.4%	-4473.2%	-2729.9%	-5482.0%	-2251.0%	-1987.5%	-2751.5%	-2478.3%	-735.7%	-837.5%	-1046.6%	-1460.7%	-549.8%	-1731.8%	-2365.4%	-1141.4%	-1338.9%	-959.4%	-305.0%	—	-1396.5%	-17.1%	-1970.8%	-2160.8%	-11012.3%	-13685.6%	-3527.8%	-212.0%	-95.5%	14.7%	-56.0%	-251.7%	-167.2%	—	38.5%	-510.9%	-580.2%	—	-214.0%	-68.2%	-3052.6%

Returns & leverage

Quarterly · %

ROE -68.3% ROA -50.0% Debt ratio 18.8%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	—	—	—	-24.7%	-16.1%	-18.9%	-59.5%	-38.4%	-52.0%	-46.0%	-57.0%	-74.3%	-102.4%	-77.7%	-102.0%	-137.6%	-101.4%	-108.0%	-157.9%	-282.5%	-180.9%	-251.1%	-159.5%	-204.6%	-393.3%	-1649.5%	-168.3%	-212.1%	-445.7%	-455.1%	-1204.8%	—	—	—	—	—	—	—	-281.8%	-77.9%	-113.9%	-191.3%	-91.6%	-56.2%	-53.7%	-68.3%
ROA	—	—	—	—	-178.0%	—	—	-19.5%	-22.8%	-14.9%	-16.5%	-35.1%	-33.5%	-44.2%	-39.2%	-47.3%	-58.9%	-77.0%	-44.0%	-52.8%	-61.4%	-53.6%	-43.7%	-52.0%	-66.8%	-58.9%	-66.3%	-54.1%	-53.2%	-60.2%	-69.8%	-45.5%	-50.3%	-57.4%	-57.2%	-80.0%	-91.6%	-69.7%	-59.2%	-44.5%	-27.3%	-24.5%	-33.5%	-51.0%	-30.9%	-42.9%	-56.3%	-40.7%	-41.3%	-42.1%	-50.0%
Debt ratio	—	—	—	—	31.0%	—	—	5.1%	2.5%	2.6%	8.5%	11.7%	13.4%	17.5%	13.1%	14.0%	18.8%	21.6%	58.4%	64.7%	72.5%	52.5%	56.4%	64.7%	74.8%	88.0%	98.3%	62.5%	67.5%	75.0%	85.6%	81.2%	80.5%	95.3%	81.8%	98.2%	125.4%	110.0%	119.1%	116.3%	82.7%	85.9%	97.9%	58.3%	38.3%	37.7%	41.7%	45.1%	17.6%	12.3%	18.8%

EPS

Quarterly · US$

EPS US$-0.34

Show table：EPS

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.78	-0.12	-0.61	-0.62	-0.62	-0.42	-0.45	-0.27	-0.20	0.07	-0.15	-0.24	-0.25	-0.47	0.27	-0.29	-0.31	-0.32	-0.29	-0.13	-0.34

Revenue & profit

Year-to-date · In mn (USD)

Revenue 40.5 mn Net income -95.4 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 558 mn Total liabilities 105 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -113 mn Investing -124 mn Financing 2.86 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin -259.4% Net margin -235.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -68.3% ROA -50.0% Debt ratio 18.8%

EPS

Year-to-date · US$

EPS US$-0.47

Revenue & profit

Annual · In mn (USD)

Revenue 113 mn Net income -204 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	—	0.15	—	3.89	14.4	16.0	20.1	—	3.65	113	—	—
Operating income	—	-19.3	-55.3	-103	-160	-208	-153	-127	-163	-68.0	-110	-215
Net income	-5.23	-19.2	-55.4	-102	-147	-194	-150	-122	-162	-57.5	-97.0	-204

Balance sheet

Annual · In mn (USD)

Total assets 639 mn Total liabilities 112 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	1.49	161	152	150	202	185	230	163	98.5	235	320	615
Total assets	2.94	165	165	182	296	284	279	207	146	275	352	639
Current liabilities	0.88	3.82	12.2	19.6	130	118	121	64.2	71.5	186	111	95.1
Total liabilities	0.91	4.06	22.1	34.2	215	213	189	167	184	227	135	112
Equity	2.03	153	135	140	73.3	63.7	82.8	32.5	-45.1	39.6	210	518

Cash flow

Annual · In mn (USD)

Operating -187 mn Investing -0.72 mn Financing 488 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	—	-12.5	-31.9	-83.7	-22.9	-188	-116	-89.0	-128	-19.4	-151	-187
Investing	—	-2.91	-5.56	-18.9	-9.94	-3.92	-1.34	-0.56	-1.25	-1.11	-0.94	-0.72
Financing	—	176	29.1	94.4	65.1	164	155	55.8	67.2	133	254	488
Cash at period end	1.05	161	150	143	175	147	185	151	88.5	200	302	602

Profitability

Annual · %

Operating margin -60.0% Net margin -50.8%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	—	-12696.0%	—	-2635.0%	-1106.7%	-1303.4%	-763.9%	—	-4459.3%	-60.0%	—	—
Net margin	—	-12631.6%	—	-2621.0%	-1017.4%	-1211.5%	-746.7%	—	-4434.7%	-50.8%	—	—

Returns & leverage

Annual · %

ROE -56.2% ROA -41.3% Debt ratio 17.6%

Show table：Returns & leverage

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-258.0%	-24.7%	-38.4%	-74.3%	-137.6%	-282.5%	-204.6%	-212.1%	—	—	-77.9%	-56.2%
ROA	-178.0%	-22.8%	-33.5%	-58.9%	-61.4%	-66.8%	-53.2%	-50.3%	-91.6%	-27.3%	-30.9%	-41.3%
Debt ratio	31.0%	2.5%	13.4%	18.8%	72.5%	74.8%	67.5%	80.5%	125.4%	82.7%	38.3%	17.6%

EPS

Annual · US$

EPS US$-1.21

Show table：EPS

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	—	—	—	—	-2.11	-0.55	-0.69	-1.21

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Wave Life Sciences Ltd. (WVE) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.